Aier(SZ:300015)2017-07-13 16:00Financial Performance - The company expects a net profit of approximately RMB 340.94 million to RMB 368.22 million for the first half of 2017, representing a year-on-year growth of 25%-35%[3] - The net profit for the same period last year was RMB 272.75 million[3] - The increase in net profit is attributed to the growing demand for ophthalmic medical services and the strengthening brand influence of the company[5] - The company anticipates a negative impact of approximately RMB 9 million from non-recurring gains and losses on net profit during this reporting period[7] - The operational efficiency of the company has improved, contributing to sustained growth in revenue and net profit[5] - The company continues to expand its operational scale during the reporting period[5] Financial Reporting - The financial data in this earnings forecast has not been audited by a registered accountant[4] - The earnings forecast is based on preliminary calculations by the company's finance department, with detailed financial data to be disclosed in the half-year report[7] - The reporting period for the earnings forecast is from January 1, 2017, to June 30, 2017[3] Investor Guidance - The company emphasizes the importance of rational investment and risk awareness for investors[7]